FATE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $166,023.60

Insider Selling (Last 12 Months): $202,409.98

Fate Therapeutics Insider Trading History Chart

Fate Therapeutics Share Price & Price History

^$1.74

▼ -0.14 (-7.45%)

As of 12/18/2024 12:03 PM ET

Days: 30 | 90 | 365

DeFi Coin on Verge of Breakout!

From Crypto 101 Media | Ad

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!

Fate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/6/2024	Yuan Xu	Director	Sell	633	$4.23	$2,677.59	8,669
1/29/2024	Edward J. Dulac, III	CFO	Sell	1,849	$5.00	$9,245.00	103,926
1/9/2024	Bahram Valamehr	Insider	Sell	11,271	$4.38	$49,366.98	158,069
1/9/2024	Cindy Tahl	General Counsel	Sell	10,874	$4.37	$47,519.38	142,361
1/9/2024	Edward J. Dulac, III	CFO	Sell	7,028	$4.37	$30,712.36	105,775
1/9/2024	J. Scott Wolchko	CEO	Sell	14,391	$4.37	$62,888.67	371,248
12/26/2023	Redmile Group, Llc	Director	Buy	44,630	$3.72	$166,023.60	13,180,388
8/18/2023	Edward J. Dulac, III	CFO	Sell	4,718	$2.80	$13,210.40	119,570
8/4/2023	Yuan Xu	Director	Sell	632	$3.71	$2,344.72	9,302
7/5/2023	Brian T Powl	Insider	Sell	3,854	$4.87	$18,768.98	41,146
7/5/2023	Edward J. Dulac, III	CFO	Sell	5,182	$4.83	$25,029.06	124,288
6/14/2023	Yuan Xu	Director	Sell	3,460	$5.58	$19,306.80	9,934
4/20/2023	Redmile Group, Llc	Director	Buy	20,000	$5.99	$119,800.00	12,879,119
4/18/2023	Yu-Waye Chu	Insider	Sell	2,532	$6.57	$16,635.24	140,676
4/14/2023	Redmile Group, Llc	Director	Buy	25,700	$6.00	$154,200.00	12,859,119
1/13/2023	John Mendlein	Director	Buy	36,631	$5.43	$198,906.33	282,770
1/11/2023	John Mendlein	Director	Buy	88,048	$5.67	$499,232.16	246,139
1/10/2023	Bahram Valamehr	Insider	Sell	10,917	$5.24	$57,205.08	168,917
1/10/2023	Cindy Tahl	General Counsel	Sell	11,553	$5.24	$60,537.72	177,598
1/10/2023	Edward J. Dulac, III	CFO	Sell	7,331	$5.24	$38,414.44	129,470
1/10/2023	J. Scott Wolchko	CEO	Sell	45,907	$5.24	$240,552.68	385,639
8/18/2022	Edward J. Dulac, III	CFO	Sell	5,135	$29.81	$153,074.35	136,801
7/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$32.88	$986,400.00	431,546
7/7/2022	Bahram Valamehr	Insider	Sell	17,158	$30.23	$518,686.34	179,834
7/5/2022	Mark Plavsic	Insider	Sell	3,719	$24.61	$91,524.59	127,123
6/7/2022	Shefali Agarwal	Director	Sell	841	$21.89	$18,409.49	1,840
6/3/2022	John Mendlein	Director	Sell	1,364	$22.79	$31,085.56	158,091
4/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$35.00	$1,050,000.00	431,546
4/19/2022	Yu-Waye Chu	Insider	Sell	4,062	$35.37	$143,672.94	151,033
4/1/2022	Cindy Tahl	General Counsel	Sell	25,000	$38.85	$971,250.00	189,151
3/10/2022	John Mendlein	Director	Sell	31,562	$35.02	$1,105,301.24
1/20/2022	J. Scott Wolchko	CEO	Sell	30,000	$40.21	$1,206,300.00
1/11/2022	Edward J. Dulac, III	CFO	Sell	1,770	$48.45	$85,756.50
1/11/2022	Yu-Waye Chu	VP	Sell	3,965	$48.51	$192,342.15
1/10/2022	Bahram Valamehr	Insider	Sell	5,596	$46.38	$259,542.48
1/10/2022	Cindy Tahl	General Counsel	Sell	7,738	$46.43	$359,275.34
1/10/2022	J. Scott Wolchko	CEO	Sell	34,156	$46.86	$1,600,550.16
12/20/2021	Edward J. Dulac, III	CFO	Sell	15,977	$60.00	$958,620.00

DeFi Coin on Verge of Breakout!

From Crypto 101 Media | Ad

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

97.54% of Fate Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	150,821	$0.53M	0.0%	-34.4%	0.132%
11/19/2024	Barclays PLC	424,277	$1.49M	0.0%	+245.3%	0.373%
11/16/2024	Geode Capital Management LLC	2,258,246	$7.91M	0.0%	+0.5%	1.983%
11/15/2024	Barclays PLC	424,277	$1.49M	0.0%	+245.3%	0.373%
11/15/2024	Jane Street Group LLC	147,872	$0.52M	0.0%	-32.1%	0.130%
11/15/2024	State Street Corp	5,252,974	$18.39M	0.0%	-1.6%	4.613%
11/15/2024	Stifel Financial Corp	24,096	$84K	0.0%	-41.9%	0.021%
11/15/2024	Jacobs Levy Equity Management Inc.	1,587,900	$5.56M	0.0%	-6.3%	1.394%
11/14/2024	Vestal Point Capital LP	1,685,000	$5.90M	0.4%	-15.8%	1.480%
11/14/2024	Walleye Capital LLC	67,609	$0.24M	0.0%	+263.5%	0.059%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	142,131	$0.50M	0.0%	-24.6%	0.125%
11/14/2024	MetLife Investment Management LLC	42,652	$0.15M	0.0%	-28.9%	0.037%
11/13/2024	BNP Paribas Financial Markets	174,148	$0.61M	0.0%	+1,307.6%	0.153%
11/13/2024	FMR LLC	227,981	$0.80M	0.0%	+25.9%	0.200%
11/12/2024	Charles Schwab Investment Management Inc.	763,808	$2.67M	0.0%	-13.1%	0.671%
11/9/2024	Intech Investment Management LLC	30,946	$0.11M	0.0%	N/A	0.027%
11/7/2024	Thrivent Financial for Lutherans	125,370	$0.44M	0.0%	+24.7%	0.110%
11/6/2024	Cornercap Investment Counsel Inc.	20,683	$72K	0.0%	-52.4%	0.018%
11/5/2024	Victory Capital Management Inc.	12,078	$42K	0.0%	-88.4%	0.011%
11/2/2024	Privium Fund Management B.V.	50,000	$0.18M	0.0%	N/A	0.044%
10/23/2024	Assenagon Asset Management S.A.	2,434,198	$8.52M	0.0%	-5.5%	2.138%
10/21/2024	Castleview Partners LLC	20,826	$73K	0.0%	N/A	0.018%
10/10/2024	Exchange Traded Concepts LLC	42,289	$0.15M	0.0%	+40.7%	0.037%
8/16/2024	Perceptive Advisors LLC	345,575	$1.13M	0.0%	N/A	0.304%
8/16/2024	Doheny Asset Management CA	7,670	$0.26M	0.1%	N/A	0.007%
8/16/2024	Algert Global LLC	65,611	$0.22M	0.0%	+318.4%	0.058%
8/15/2024	Susquehanna Fundamental Investments LLC	262,414	$0.86M	0.0%	+73.6%	0.231%
8/15/2024	The Manufacturers Life Insurance Company	39,715	$0.13M	0.0%	-33.6%	0.035%
8/15/2024	Dark Forest Capital Management LP	19,065	$63K	0.0%	N/A	0.017%
8/15/2024	Deerfield Management Company L.P. Series C	3,555,871	$11.66M	0.2%	+62.3%	3.124%
8/15/2024	AQR Capital Management LLC	16,460	$54K	0.0%	-25.5%	0.014%
8/15/2024	Caxton Associates LP	172,863	$0.57M	0.0%	-40.4%	0.152%
8/14/2024	Squarepoint Ops LLC	128,759	$0.42M	0.0%	N/A	0.113%
8/14/2024	Marshall Wace LLP	330,082	$1.08M	0.0%	-4.4%	0.290%
8/14/2024	Integral Health Asset Management LLC	850,000	$2.79M	0.3%	+325.0%	0.747%
8/14/2024	DRW Securities LLC	21,550	$71K	0.0%	N/A	0.019%
8/14/2024	ProShare Advisors LLC	11,351	$37K	0.0%	-25.5%	0.010%
8/14/2024	Profund Advisors LLC	46,528	$0.15M	0.0%	-58.6%	0.041%
8/12/2024	XTX Topco Ltd	33,898	$0.11M	0.0%	+95.0%	0.030%
8/12/2024	Hsbc Holdings PLC	88,514	$0.28M	0.0%	+34.3%	0.078%
8/12/2024	E Fund Management Co. Ltd.	355,225	$1.17M	0.1%	+930.2%	0.312%
8/9/2024	Renaissance Technologies LLC	548,544	$1.80M	0.0%	N/A	0.482%
8/9/2024	Dimensional Fund Advisors LP	2,130,280	$6.99M	0.0%	+100.4%	1.871%
8/9/2024	Massachusetts Financial Services Co. MA	167,055	$0.55M	0.0%	+3.5%	0.147%
8/9/2024	Bruce & Co. Inc.	300,000	$0.98M	0.3%	+109.8%	0.264%
8/8/2024	Federated Hermes Inc.	1,031,505	$3.38M	0.0%	+2.4%	0.906%
8/8/2024	American Century Companies Inc.	166,255	$0.55M	0.0%	+26.4%	0.146%
8/7/2024	Headlands Technologies LLC	28,508	$94K	0.0%	+5,258.6%	0.025%
8/7/2024	Doheny Asset Management CA	7,670	$0.26M	0.2%	N/A	0.007%
8/7/2024	Monaco Asset Management SAM	286,900	$0.94M	0.1%	-9.4%	0.252%
8/6/2024	Ausdal Financial Partners Inc.	10,007	$33K	0.0%	N/A	0.009%
8/6/2024	Acadian Asset Management LLC	2,008,862	$6.59M	0.0%	+17.2%	1.765%
8/5/2024	Arizona State Retirement System	25,486	$84K	0.0%	N/A	0.022%
8/5/2024	Victory Capital Management Inc.	104,019	$0.34M	0.0%	-43.5%	0.091%
8/1/2024	Rhumbline Advisers	160,001	$0.53M	0.0%	+11.0%	0.141%
7/29/2024	Principal Financial Group Inc.	13,668	$45K	0.0%	-42.8%	0.012%
7/26/2024	Bank of New York Mellon Corp	374,132	$1.23M	0.0%	+23.9%	0.329%
7/18/2024	Assenagon Asset Management S.A.	2,574,703	$8.45M	0.0%	+1.0%	2.262%
5/17/2024	Artal Group S.A.	360,311	$2.65M	0.1%	N/A	0.317%
5/16/2024	California State Teachers Retirement System	8,520	$63K	0.0%	-38.9%	0.007%
5/16/2024	Jacobs Levy Equity Management Inc.	1,999,822	$14.68M	0.1%	-23.6%	1.757%
5/16/2024	Bayesian Capital Management LP	39,800	$0.29M	0.0%	+102.7%	0.035%
5/16/2024	Caxton Associates LP	290,187	$2.13M	0.1%	N/A	0.255%
5/15/2024	Baker BROS. Advisors LP	1,818,181	$13.35M	0.2%	N/A	1.597%
5/15/2024	Public Employees Retirement System of Ohio	147,799	$1.09M	0.0%	-4.1%	0.130%
5/15/2024	Bellevue Group AG	4,839,779	$35.52M	0.5%	-0.2%	4.252%
5/15/2024	Price T Rowe Associates Inc. MD	274,289	$2.01M	0.0%	+404.6%	0.241%
5/10/2024	Acadian Asset Management LLC	1,714,124	$12.58M	0.0%	-24.9%	1.506%
5/10/2024	Vanguard Group Inc.	9,911,007	$72.75M	0.0%	+6.6%	8.708%
5/9/2024	Monaco Asset Management SAM	316,805	$2.33M	0.7%	-85.5%	0.278%
5/8/2024	Russell Investments Group Ltd.	110,248	$0.81M	0.0%	-52.8%	0.097%
5/7/2024	Susquehanna Fundamental Investments LLC	151,121	$1.11M	0.1%	N/A	0.133%
5/7/2024	SG Americas Securities LLC	37,456	$0.28M	0.0%	-58.6%	0.033%
5/1/2024	BNP Paribas Financial Markets	46,962	$0.35M	0.0%	+100.9%	0.041%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	58,835	$0.43M	0.0%	N/A	0.052%
4/29/2024	Principal Financial Group Inc.	23,876	$0.18M	0.0%	-10.9%	0.021%
4/24/2024	Simplicity Wealth LLC	11,016	$81K	0.0%	N/A	0.010%
4/24/2024	Assenagon Asset Management S.A.	2,548,304	$18.71M	0.0%	+1,462.4%	2.239%
2/14/2024	Pennant Investors LP	146,100	$0.55M	0.1%	N/A	0.148%
2/14/2024	Superstring Capital Management LP	847,823	$3.17M	2.3%	N/A	0.860%
2/14/2024	Vestal Point Capital LP	1,290,000	$4.83M	0.5%	N/A	1.308%
2/13/2024	Tower Research Capital LLC TRC	15,233	$57K	0.0%	-62.7%	0.015%
2/12/2024	Bruce & Co. Inc.	143,000	$0.54M	0.2%	-28.5%	0.145%
2/12/2024	RPO LLC	12,307	$46K	0.1%	N/A	0.012%
2/8/2024	Panagora Asset Management Inc.	356,740	$1.33M	0.0%	-16.4%	0.362%
2/8/2024	Vanguard Personalized Indexing Management LLC	12,357	$46K	0.0%	-13.9%	0.013%
2/7/2024	Monaco Asset Management SAM	2,183,228	$8.17M	2.4%	+18.1%	2.214%
2/6/2024	National Bank of Canada FI	7,000	$26K	0.0%	-41.7%	0.007%
2/5/2024	Victory Capital Management Inc.	12,504	$47K	0.0%	+22.8%	0.013%
2/5/2024	Russell Investments Group Ltd.	233,748	$0.87M	0.0%	+34.0%	0.237%
1/31/2024	Knights of Columbus Asset Advisors LLC	32,184	$0.12M	0.0%	+100.0%	0.033%
1/31/2024	Federated Hermes Inc.	1,849,872	$6.92M	0.0%	-24.5%	1.876%
1/26/2024	Cerity Partners LLC	32,174	$0.12M	0.0%	N/A	0.033%
1/25/2024	Nisa Investment Advisors LLC	16,840	$63K	0.0%	+1,069.4%	0.017%
1/17/2024	Assenagon Asset Management S.A.	163,097	$0.61M	0.0%	-57.2%	0.165%
1/12/2024	SG Americas Securities LLC	90,553	$0.34M	0.0%	+23.0%	0.092%
1/11/2024	Epiq Partners LLC	10,071	$38K	0.0%	N/A	0.010%
1/5/2024	Exchange Traded Concepts LLC	63,725	$0.24M	0.0%	+34.0%	0.065%
12/19/2023	Public Employees Retirement System of Ohio	154,178	$0.33M	0.0%	+14.7%	0.156%
12/18/2023	Vanguard Group Inc.	10,908,351	$23.13M	0.0%	-7.0%	11.063%

Data available starting January 2016

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $1.74

$1.74

$1.88

50 Day Range

MA: $2.63

$1.83

$3.23

52 Week Range

Now: $1.74

$1.74

$8.83

Volume

973,415 shs

Average Volume

2,401,163 shs

Market Capitalization

$198.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.95

Who are the company insiders with the largest holdings of Fate Therapeutics?: Fate Therapeutics' top insider investors include:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
John Mendlein (Director)
Cindy Tahl (General Counsel)
Bahram Valamehr (Insider)
Yu-Waye Chu (Insider)
Edward J Dulac III (CFO)
Brian T Powl (Insider)
Yuan Xu (Director)
Learn More about top insider investors at Fate Therapeutics.
Who are the major institutional investors of Fate Therapeutics?: Fate Therapeutics' top institutional investors include:
State Street Corp — 4.61%
Assenagon Asset Management S.A. — 2.14%
Geode Capital Management LLC — 1.98%
Vestal Point Capital LP — 1.48%
Jacobs Levy Equity Management Inc. — 1.39%
Charles Schwab Investment Management Inc. — 0.67%
Learn More about top institutional investors of Fate Therapeutics stock.
Which institutional investors are selling Fate Therapeutics stock?: Within the previous quarter, FATE stock was sold by these institutional investors:
Vestal Point Capital LP
Assenagon Asset Management S.A.
Charles Schwab Investment Management Inc.
Jacobs Levy Equity Management Inc.
Victory Capital Management Inc.
State Street Corp
Franklin Resources Inc.
Jane Street Group LLC
In the last year, company insiders that have sold Fate Therapeutics company stock include:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
John Mendlein (Director)
Cindy Tahl (General Counsel)
Bahram Valamehr (Insider)
Learn More investors selling Fate Therapeutics stock.
Which institutional investors are buying Fate Therapeutics stock?: During the previous quarter, FATE stock was acquired by institutional investors including:
Barclays PLC
Barclays PLC
BNP Paribas Financial Markets
Privium Fund Management B.V.
Walleye Capital LLC
FMR LLC
Intech Investment Management LLC
Thrivent Financial for Lutherans
Within the last year, these company insiders have bought Fate Therapeutics stock:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
Learn More investors buying Fate Therapeutics stock.